Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

07 févr. 2023 02h00 HE | Source: Nodus Oncology

Nodus Oncology Secures £2.4m ($2.9m) Investment

Nodus Oncology Secures £2.4m ($2.9m) Investment KHAN Technology Transfer Fund I (KHAN-I) have invested alongside existing investor Cumulus Oncology Bert Klebl, Managing Director of KHAN-I will join...
08 sept. 2022 01h15 HE | Source: Nodus Oncology

Nodus Oncology announces acquisition of Basilea Pharmaceutica’s PARG inhibitor programme

Nodus Oncology announces acquisition of Basilea Pharmaceutica’s PARG inhibitor programme Acquisition enables Nodus Oncology to continue building its portfolio of first and best-in-class molecules...
06 sept. 2022 02h00 HE | Source: Nodus Oncology

Nodus Oncology launches, founded by Cumulus Oncology and in partnership with the Lead Discovery Center, to focus on developing first and best-in-class molecules inhibiting novel DNA damage response targets

Nodus Oncology launches, founded by Cumulus Oncology and in partnership with the Lead Discovery Center, to focus on developing first and best-in-class molecules inhibiting novel DNA damage response...